Accolade, Inc.

  • Market Cap: Micro Cap
  • Industry: Information Technology Services
  • ISIN: US00437E1029
USD
7.02
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

0

Shareholding (Nov 2024)

FII

14.57%

Held by 87 FIIs

DII

46.19%

Held by 37 DIIs

Promoter

11.04%

How big is Accolade, Inc.?

22-Jun-2025

As of Apr 09, Accolade, Inc. has a market capitalization of 575.59 million and net sales of 446.72 million, with a net profit of -180.29 million over the latest four quarters. Shareholder's funds are 445.46 million, and total assets amount to 788.15 million as of Feb 24.

As of Apr 09, Accolade, Inc. has a market capitalization of 575.59 million, categorizing it as a Micro Cap company.<BR><BR>As of Apr 09, the sum of Net Sales for the latest four quarters is 446.72 million, while the sum of Net Profit for the same period is -180.29 million.<BR><BR>As of Feb 24, the reporting period shows Shareholder's Funds at 445.46 million and Total Assets at 788.15 million.

Read More

What does Accolade, Inc. do?

22-Jun-2025

Accolade, Inc. provides personalized, technology-enabled healthcare and workplace benefits solutions. As of November 2024, it reported net sales of $105 million and a net loss of $121 million, with a market cap of $575.59 million.

Overview: <BR>Accolade, Inc. is a provider of personalized, technology-enabled solutions that assist individuals in navigating the healthcare system and workplace benefits, operating within the Information Technology Services industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 105 Million (Quarterly Results - Nov 2024) <BR>Most recent Net Profit: -121 Million (Quarterly Results - Nov 2024) <BR>Market-cap: USD 575.59 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 92.37% <BR>Debt Equity: -0.03 <BR>Return on Equity: -26.16% <BR>Price to Book: 1.84<BR><BR>Contact Details: <BR>Address: 660 West Germantown Pike, Suite 500, PLYMOUTH MEETING PA: 19462 <BR>Tel: 1 610 8342989 <BR>Website: https://www.accolade.com

Read More

Should I buy, sell or hold Accolade, Inc.?

22-Jun-2025

Who are in the management team of Accolade, Inc.?

22-Jun-2025

As of March 2022, the management team of Accolade, Inc. includes Chairman J. Michael Cline, CEO Rajeev Singh, and independent directors Dr. William Frist, Jeffrey Jordan, Peter Klein, Dawn Lepore, and James Madden, who oversee the company's strategic direction and governance.

As of March 2022, the management team of Accolade, Inc. includes the following individuals:<BR><BR>- Mr. J. Michael Cline, Chairman of the Board<BR>- Mr. Rajeev Singh, Chief Executive Officer and Director<BR>- Dr. William Frist, Independent Director<BR>- Mr. Jeffrey Jordan, Independent Director<BR>- Mr. Peter Klein, Independent Director<BR>- Ms. Dawn Lepore, Independent Director<BR>- Mr. James Madden, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and governance.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Nov 24

  • DEBT-EQUITY RATIO (HY) Highest at 3.97 %
  • EPS(Q) Lowest at USD -1.5 MM
2

Risky - Not traded in last 10 days

3

High Institutional Holdings at 98.34%

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Information Technology Services

stock-summary
Market cap

USD 576 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

92.37%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

-26.16%

stock-summary
Price to Book

1.84

Revenue and Profits:
Net Sales:
105 Million
(Quarterly Results - Nov 2024)
Net Profit:
-121 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.33%
0%
2.33%
6 Months
80.0%
0%
80.0%
1 Year
-26.88%
0%
-26.88%
2 Years
-48.31%
0%
-48.31%
3 Years
-54.45%
0%
-54.45%
4 Years
-85.12%
0%
-85.12%
5 Years
0%
0%
0.0%

Accolade, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
29.39%
EBIT Growth (5y)
-17.48%
EBIT to Interest (avg)
-67.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.58
Tax Ratio
0.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
98.34%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.84
EV to EBIT
-6.59
EV to EBITDA
-13.44
EV to Capital Employed
1.86
EV to Sales
1.27
PEG Ratio
NA
Dividend Yield
92.37%
ROCE (Latest)
-28.26%
ROE (Latest)
-26.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Nov 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 45 Schemes (28.18%)

Foreign Institutions

Held by 87 Foreign Institutions (14.57%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Nov 2024 is 5.73% vs 9.35% in Nov 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Nov 2024 is -474.88% vs 47.12% in Nov 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'24",
        "Nov'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.10",
          "val2": "99.40",
          "chgp": "5.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.80",
          "val2": "-20.50",
          "chgp": "32.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-98.50",
          "val2": "9.40",
          "chgp": "-1,147.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-121.30",
          "val2": "-21.10",
          "chgp": "-474.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-227.10%",
          "val2": "-320.80%",
          "chgp": "9.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2024 is 14.10% vs 17.13% in Feb 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2024 is 78.29% vs -273.35% in Feb 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'24",
        "Feb'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "414.30",
          "val2": "363.10",
          "chgp": "14.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-63.00",
          "val2": "-108.10",
          "chgp": "41.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.90",
          "val2": "3.30",
          "chgp": "-12.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.40",
          "val2": "-308.00",
          "chgp": "102.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-99.80",
          "val2": "-459.60",
          "chgp": "78.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-274.20%",
          "val2": "-428.30%",
          "chgp": "15.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Nov'24 - YoYstock-summary
Nov'24
Nov'23
Change(%)
Net Sales
105.10
99.40
5.73%
Operating Profit (PBDIT) excl Other Income
-13.80
-20.50
32.68%
Interest
0.00
0.00
Exceptional Items
-98.50
9.40
-1,147.87%
Consolidate Net Profit
-121.30
-21.10
-474.88%
Operating Profit Margin (Excl OI)
-227.10%
-320.80%
9.37%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Nov 2024 is 5.73% vs 9.35% in Nov 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Nov 2024 is -474.88% vs 47.12% in Nov 2023

Annual Results Snapshot (Consolidated) - Feb'24stock-summary
Feb'24
Feb'23
Change(%)
Net Sales
414.30
363.10
14.10%
Operating Profit (PBDIT) excl Other Income
-63.00
-108.10
41.72%
Interest
2.90
3.30
-12.12%
Exceptional Items
8.40
-308.00
102.73%
Consolidate Net Profit
-99.80
-459.60
78.29%
Operating Profit Margin (Excl OI)
-274.20%
-428.30%
15.41%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Feb 2024 is 14.10% vs 17.13% in Feb 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Feb 2024 is 78.29% vs -273.35% in Feb 2023

stock-summaryCompany CV
About Accolade, Inc. stock-summary
stock-summary
Accolade, Inc.
Information Technology Services
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). It leverages its integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population. The Company’s offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits and Accolade Boost.
Company Coordinates stock-summary
Company Details
660 West Germantown Pike, Suite 500 , PLYMOUTH MEETING PA : 19462
stock-summary
Tel: 1 610 8342989
stock-summary
Registrar Details